AMAG Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
AMAG AMAG Pharmaceuticals Inc
HCI Hci Group Inc
PSF Cohen & Steers Select Preferred and Income Fund
PJT PJT Partners Inc
ALK Alaska Air Group Inc
RS Reliance Steel & Aluminum Co
HFWA Heritage Financial Corp
MET MetLife Inc
KALU Kaiser Aluminum Corp
STBA S&T Bancorp Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Closing Price
$13.67
Day's Change
0.01 (0.07%)
Bid
--
Ask
--
B/A Size
--
Day's High
13.67
Day's Low
13.61
Volume
(Light)
Volume:
723,563

10-day average volume:
1,312,130
723,563

UPDATE: Dow sinks at Wednesday's open but Nasdaq trades flat as Wall St. worries about rising trade tensions and coronavirus cases

9:43 am ET June 24, 2020 (MarketWatch)
Print

U.S. stocks opened firmly lower Wednesday morning, threatening to snap an eight-session win streak for the Nasdaq Composite, amid signs of rising coronavirus cases and worries about fresh international trade tensions. Those concerns have under cut enthusiasm for equities, which have already enjoyed a blistering rebound from their March lows. The Dow Jones Industrial Average was trading 222 points, or 0.8%, lower at 25,939, the S&P 500 index was off 0.6% at 3,113, while the Nasdaq Composite Index was off less than 0.1% at 10,104, after posting its second straight record close on Tuesday and its eight consecutive advance, widening a performance gap between the technology-laden index and broader market benchmarks. Reports of possible trade tensions between the U.S. and its European and North American allies, was drawing attention after, Bloomberg indicated that the Trump administration was considering imposing tariffs on an array of goods from Europe totaling some $3.1 billion as well as reimposing tariffs on aluminum imports from Canada. Meanwhile, New COVID-19 cases have jumped in several states, with Arizona, Texas and California reporting daily records of infections Tuesday. Signs of rising cases threatens efforts to restart economies that have been locked down to help limit the spread of the epidemic. Meanwhile, the International Monetary Fund on Wednesday lowered global growth expectations by 2 percentage points for this year to negative 4.9%. In corporate news, shares of Hertz Global Holdings Inc. (HTZ) were jumping on rumors that the troubled car-rental company may be purchased in bankruptcy.

-Mark DeCambre; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

June 24, 2020 09:43 ET (13:43 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.